Corrigendum to “Effectiveness,safety,and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohort”
Restricted accessCorrectionFirst published online March, 2025
Corrigendum to “Effectiveness,safety,and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohort”